All Articles

Veeva's new Falcon MLR promises to automate 70% of pharma's regulatory review bottleneck. It's a bold play, but can autonomous AI truly master the high-stakes world of compliance?

A landmark MOU between China's ChinaAMC and South Korea's KBAM signals a new era for Asian finance, promising to build a superhighway for cross-border investment.

Metalla Royalty & Streaming unveils its 2026 Asset Handbook, detailing a portfolio built over a decade. Is its patient, counter-cyclical strategy timed perfectly?

A new report reveals high patient volume is the top cause of burnout in oncology. Now, centers are betting on AI and optimization, not just hiring, to survive.

A $41B AI education market is exploding, but a deep global divide in strategy and a massive teacher training gap threaten to turn progress into peril.

The N2 Company is digitizing its exclusive community stories for America's 250th. Is this patriotic goodwill or a masterclass in operational innovation?

As diamond mines close, federal announcements in Yellowknife signal a major shift to critical minerals and new energy tech. But can it deliver a sustainable future?

Startup Airrived ranked #1 in a top AWS accelerator, heralding a shift from AI assistants to governed, autonomous agents reshaping global business.

With a major drill program set for its Advocate property, FPX Nickel isn't just digging for nickel; it's drilling into a future of cleaner processing and growth.

Chinese fintech leader Jiayin Group reports a stunning Q1 loss as revenue halves, reflecting a sector-wide crisis. A defensive pivot is underway.

Amid record charter rates, Dorian LPG sells older vessels to fund a new, eco-friendly ship designed to bypass Panama Canal congestion. A deep dive into the strategy.

Ceva's RealSpace Elevate isn't just another audio feature; it's a strategic weapon for headset makers and a competitive edge for gamers in a crowded market.

A pivotal NCCN guideline update for bladder cancer validates Natera's Signatera test, ushering in a new era of personalized, MRD-guided cancer treatment.

A 158-year-old chocolate maker is tackling a modern baker's biggest headache. Guittard's new baton isn't just chocolate; it's a lesson in operational excellence.

A single jet delivery reveals the hidden strategies of leasing giants and airline renewals, powered by digital efficiency and reshaping global travel networks.

A new partnership between Synthflow AI and AVANT is challenging the slow pace of enterprise AI, promising sophisticated voice agent deployment in weeks, not months.

Insmed recruits J&J and Novartis veteran Samuele Butera to execute the multi-billion-dollar launch of BRINSUPRI and expand its respiratory franchise.

HLS Therapeutics is betting on itself with a larger share buyback. We analyze if this is a signal of deep value or a sign of limited growth opportunities.

The IDDeal Place opens in Palm Beach County, a beacon of hope for adults with disabilities in a state ranked 49th for I/DD care. Is this the future?

A Boston biotech advances a first-in-class antibody into trials, aiming to halt the cellular engine of fibrosis that drives chronic kidney disease.